Report Detail
Global Oncolytic Virus Drug Treatment Market Research Report 2022
- RnM4440740 |
- 17 May, 2022 |
- Global |
- 86 Pages |
- QYResearch |
- Pharma & Healthcare
Summary:
Industry Insights
The global Oncolytic Virus Drug Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Phase 1 accounting for % of the Oncolytic Virus Drug Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Melanoma segment is altered to an % CAGR throughout this forecast period.
China Oncolytic Virus Drug Treatment market size is valued at US$ million in 2021, while the North America and Europe Oncolytic Virus Drug Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Oncolytic Virus Drug Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oncolytic Virus Drug Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oncolytic Virus Drug Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oncolytic Virus Drug Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oncolytic Virus Drug Treatment market.
Impact of Covid-19 Outbreak
This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
Segmental Analysis
The report has been segmented into product and application segments. The researchers have documented all the products present today in the Oncolytic Virus Drug Treatment market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
Oncolytic Virus Drug Treatment Breakdown Data by Clinical Stage
Phase 1
Phase 2
Others
Oncolytic Virus Drug Treatment Breakdown Data by Application
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
Regional Analysis
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
Frequently Asked Questions
What factors will challenge the Oncolytic Virus Drug Treatment market growth?
Which end-use segment will expand at the fastest CAGR in the Oncolytic Virus Drug Treatment market?
Which are the emerging players in the Oncolytic Virus Drug Treatment market?
How concentrated is the Oncolytic Virus Drug Treatment market?
Which factors are positively contributing to the Oncolytic Virus Drug Treatment market growth?
Which are the novel product innovations in the Oncolytic Virus Drug Treatment market?
Which product segment will emerge as the most lucrative in the Oncolytic Virus Drug Treatment market?
Which factors are increasing the competition in the Oncolytic Virus Drug Treatment market?
Which are the strategic measures taken by the Oncolytic Virus Drug Treatment industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Oncolytic Virus Drug Treatment market in the coming years?
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Clinical Stage
- 1.2.1 Global Oncolytic Virus Drug Treatment Market Size Growth Rate by Clinical Stage: 2017 VS 2021 VS 2028
- 1.2.2 Phase 1
- 1.2.3 Phase 2
- 1.2.4 Others
- 1.3 Market by Application
- 1.3.1 Global Oncolytic Virus Drug Treatment Market Share by Application: 2017 VS 2021 VS 2028
- 1.3.2 Melanoma
- 1.3.3 Prostate Cancer
- 1.3.4 Breast Cancer
- 1.3.5 Ovarian Cancer
- 1.3.6 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Oncolytic Virus Drug Treatment Market Perspective (2017-2028)
- 2.2 Oncolytic Virus Drug Treatment Growth Trends by Region
- 2.2.1 Oncolytic Virus Drug Treatment Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Oncolytic Virus Drug Treatment Historic Market Size by Region (2017-2022)
- 2.2.3 Oncolytic Virus Drug Treatment Forecasted Market Size by Region (2023-2028)
- 2.3 Oncolytic Virus Drug Treatment Market Dynamics
- 2.3.1 Oncolytic Virus Drug Treatment Industry Trends
- 2.3.2 Oncolytic Virus Drug Treatment Market Drivers
- 2.3.3 Oncolytic Virus Drug Treatment Market Challenges
- 2.3.4 Oncolytic Virus Drug Treatment Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Oncolytic Virus Drug Treatment Players by Revenue
- 3.1.1 Global Top Oncolytic Virus Drug Treatment Players by Revenue (2017-2022)
- 3.1.2 Global Oncolytic Virus Drug Treatment Revenue Market Share by Players (2017-2022)
- 3.2 Global Oncolytic Virus Drug Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Oncolytic Virus Drug Treatment Revenue
- 3.4 Global Oncolytic Virus Drug Treatment Market Concentration Ratio
- 3.4.1 Global Oncolytic Virus Drug Treatment Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Drug Treatment Revenue in 2021
- 3.5 Oncolytic Virus Drug Treatment Key Players Head office and Area Served
- 3.6 Key Players Oncolytic Virus Drug Treatment Product Solution and Service
- 3.7 Date of Enter into Oncolytic Virus Drug Treatment Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Oncolytic Virus Drug Treatment Breakdown Data by Clinical Stage
- 4.1 Global Oncolytic Virus Drug Treatment Historic Market Size by Clinical Stage (2017-2022)
- 4.2 Global Oncolytic Virus Drug Treatment Forecasted Market Size by Clinical Stage (2023-2028)
5 Oncolytic Virus Drug Treatment Breakdown Data by Application
- 5.1 Global Oncolytic Virus Drug Treatment Historic Market Size by Application (2017-2022)
- 5.2 Global Oncolytic Virus Drug Treatment Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Oncolytic Virus Drug Treatment Market Size (2017-2028)
- 6.2 North America Oncolytic Virus Drug Treatment Market Size by Country (2017-2022)
- 6.3 North America Oncolytic Virus Drug Treatment Market Size by Country (2023-2028)
- 6.4 United States
- 6.5 Canada
7 Europe
- 7.1 Europe Oncolytic Virus Drug Treatment Market Size (2017-2028)
- 7.2 Europe Oncolytic Virus Drug Treatment Market Size by Country (2017-2022)
- 7.3 Europe Oncolytic Virus Drug Treatment Market Size by Country (2023-2028)
- 7.4 Germany
- 7.5 France
- 7.6 U.K.
- 7.7 Italy
- 7.8 Russia
- 7.9 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific Oncolytic Virus Drug Treatment Market Size (2017-2028)
- 8.2 Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Country (2017-2022)
- 8.3 Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Country (2023-2028)
- 8.4 China
- 8.5 Japan
- 8.6 South Korea
- 8.7 Southeast Asia
- 8.8 India
- 8.9 Australia
9 Latin America
- 9.1 Latin America Oncolytic Virus Drug Treatment Market Size (2017-2028)
- 9.2 Latin America Oncolytic Virus Drug Treatment Market Size by Country (2017-2022)
- 9.3 Latin America Oncolytic Virus Drug Treatment Market Size by Country (2023-2028)
- 9.4 Mexico
- 9.5 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Oncolytic Virus Drug Treatment Market Size (2017-2028)
- 10.2 Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country (2017-2022)
- 10.3 Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country (2023-2028)
- 10.4 Turkey
- 10.5 Saudi Arabia
- 10.6 UAE
11 Key Players Profiles
- 11.1 Amgen
- 11.1.1 Amgen Company Detail
- 11.1.2 Amgen Business Overview
- 11.1.3 Amgen Oncolytic Virus Drug Treatment Introduction
- 11.1.4 Amgen Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
- 11.1.5 Amgen Recent Development
- 11.2 Oncolytics Biotech
- 11.2.1 Oncolytics Biotech Company Detail
- 11.2.2 Oncolytics Biotech Business Overview
- 11.2.3 Oncolytics Biotech Oncolytic Virus Drug Treatment Introduction
- 11.2.4 Oncolytics Biotech Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
- 11.2.5 Oncolytics Biotech Recent Development
- 11.3 Viralytics
- 11.3.1 Viralytics Company Detail
- 11.3.2 Viralytics Business Overview
- 11.3.3 Viralytics Oncolytic Virus Drug Treatment Introduction
- 11.3.4 Viralytics Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
- 11.3.5 Viralytics Recent Development
- 11.4 Transgene SA
- 11.4.1 Transgene SA Company Detail
- 11.4.2 Transgene SA Business Overview
- 11.4.3 Transgene SA Oncolytic Virus Drug Treatment Introduction
- 11.4.4 Transgene SA Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
- 11.4.5 Transgene SA Recent Development
- 11.5 Oncolys BioPharma
- 11.5.1 Oncolys BioPharma Company Detail
- 11.5.2 Oncolys BioPharma Business Overview
- 11.5.3 Oncolys BioPharma Oncolytic Virus Drug Treatment Introduction
- 11.5.4 Oncolys BioPharma Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
- 11.5.5 Oncolys BioPharma Recent Development
- 11.6 Targovax
- 11.6.1 Targovax Company Detail
- 11.6.2 Targovax Business Overview
- 11.6.3 Targovax Oncolytic Virus Drug Treatment Introduction
- 11.6.4 Targovax Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
- 11.6.5 Targovax Recent Development
- 11.7 PsiOxus Therapeutics
- 11.7.1 PsiOxus Therapeutics Company Detail
- 11.7.2 PsiOxus Therapeutics Business Overview
- 11.7.3 PsiOxus Therapeutics Oncolytic Virus Drug Treatment Introduction
- 11.7.4 PsiOxus Therapeutics Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
- 11.7.5 PsiOxus Therapeutics Recent Development
- 11.8 SillaJen Biotherapeutics
- 11.8.1 SillaJen Biotherapeutics Company Detail
- 11.8.2 SillaJen Biotherapeutics Business Overview
- 11.8.3 SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Introduction
- 11.8.4 SillaJen Biotherapeutics Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
- 11.8.5 SillaJen Biotherapeutics Recent Development
- 11.9 Sorrento Therapeutics
- 11.9.1 Sorrento Therapeutics Company Detail
- 11.9.2 Sorrento Therapeutics Business Overview
- 11.9.3 Sorrento Therapeutics Oncolytic Virus Drug Treatment Introduction
- 11.9.4 Sorrento Therapeutics Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
- 11.9.5 Sorrento Therapeutics Recent Development
- 11.10 Lokon Pharma
- 11.10.1 Lokon Pharma Company Detail
- 11.10.2 Lokon Pharma Business Overview
- 11.10.3 Lokon Pharma Oncolytic Virus Drug Treatment Introduction
- 11.10.4 Lokon Pharma Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
- 11.10.5 Lokon Pharma Recent Development
- 11.11 Genelux Corporation
- 11.11.1 Genelux Corporation Company Detail
- 11.11.2 Genelux Corporation Business Overview
- 11.11.3 Genelux Corporation Oncolytic Virus Drug Treatment Introduction
- 11.11.4 Genelux Corporation Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
- 11.11.5 Genelux Corporation Recent Development
- 11.12 Vyriad
- 11.12.1 Vyriad Company Detail
- 11.12.2 Vyriad Business Overview
- 11.12.3 Vyriad Oncolytic Virus Drug Treatment Introduction
- 11.12.4 Vyriad Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
- 11.12.5 Vyriad Recent Development
- 11.13 TILT Biotherapeutics
- 11.13.1 TILT Biotherapeutics Company Detail
- 11.13.2 TILT Biotherapeutics Business Overview
- 11.13.3 TILT Biotherapeutics Oncolytic Virus Drug Treatment Introduction
- 11.13.4 TILT Biotherapeutics Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
- 11.13.5 TILT Biotherapeutics Recent Development
- 11.14 Cold Genesys
- 11.14.1 Cold Genesys Company Detail
- 11.14.2 Cold Genesys Business Overview
- 11.14.3 Cold Genesys Oncolytic Virus Drug Treatment Introduction
- 11.14.4 Cold Genesys Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
- 11.14.5 Cold Genesys Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Get latest Market Research Reports on Oncolytic Virus Drug Treatment. Industry analysis & Market Report on Oncolytic Virus Drug Treatment is a syndicated market report, published as Global Oncolytic Virus Drug Treatment Market Research Report 2022. It is complete Research Study and Industry Analysis of Oncolytic Virus Drug Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
